Q&A on the malaria vaccine implementation programme (MVIP) - Vaccine Safety Communication eLibrary - Vaccines Safety Communication eLibrary

Jump to content

To post / rate / comment on a resource, please register first.
Existing user? Sign In
Sign In

Remember me Not recommended on shared computers

Forgot your password?
Sign Up

RESOURCES
- Most popular
- Latest
- More
COMMUNITY
ABOUT
More
- More

Search In

Everywhere
Resources
This Category
This Resource
More options...

Find results that contain...

Any of my search term words
All of my search term words

Find results in...

Content titles and body
Content titles only

Resources

By ISA
May 15, 2019

Followers 0

Q&A on the malaria vaccine implementation programme (MVIP)

URL: https://www.who.int/malaria/media/malaria-vaccine-implementation-qa/en/

Source: WHO

Language(s): English

Audience: Healthcare Professionals (HCPs)

Vaccine(s): Malaria

Resource type: Frequently Asked Questions (FAQs)

Serie of questions and answers such as : What is RTS,S/AS01? What makes RTS,S different from malaria vaccine candidates currently under development? What is the efficacy of the RTS,S vaccine?
Followers 0

Go to resources
User Feedback
- 0 Comments
Recommended Comments

There are no comments to display.

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Add a comment...

× Pasted as rich text.   Paste as plain text instead

Only 75 emoji are allowed.

× Your link has been automatically embedded.   Display as a link instead

× Your previous content has been restored.   Clear editor

× You cannot paste images directly. Upload or insert images from URL.

Insert image from URL

×

Desktop

Tablet

Phone

×

RESOURCES
- Back
- Most popular
- Latest
COMMUNITY
ABOUT

×

Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines